5-Bromosalicylic acid → 5-Bromo-N-[5-phenyl-4-(trifluoromethyl)thiazol-2-yl]-2-hydroxybenzamide

HRID 421170Notes

Reaction equation

HRID 421170 reaction equation
[Br:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[NH2:12][C:13]1[S:14][C:15]([C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)=[C:16]([C:18]([F:21])([F:20])[F:19])[N:17]=1>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([OH:11])=[C:6]([CH:10]=1)[C:7]([NH:12][C:13]1[S:14][C:15]([C:22]2[CH:23]=[CH:24][CH:25]=[CH:26][CH:27]=2)=[C:16]([C:18]([F:21])([F:19])[F:20])[N:17]=1)=[O:9]

Participants

3

Procedure

Using 5-bromosalicylic acid and 2-amino-5-phenyl-4-(trifluoromethyl)thiazole as the raw materials, the same operation as the example 195(3) gave the title compound.

Sources & evidence

ORD record
ord-06025e18f6134651a16575159961e1c1
Source dataset
uspto-grants-2012_01
Patent number
US08097759B2

Reaction notes

Loading…